Lenz Therapeutics Stock Probability of Future Stock Price Finishing Over 35.5
| LENZ Stock | 35.50 1.18 3.44% |
LENZ |
LENZ Therapeutics Target Price Odds to finish over 35.5
The tendency of LENZ Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 35.50 | 90 days | 35.50 | under 4 |
Based on a normal probability distribution, the odds of LENZ Therapeutics to move above the current price in 90 days from now is under 4 (This LENZ Therapeutics probability density function shows the probability of LENZ Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days LENZ Therapeutics has a beta of -0.0684. This indicates as returns on the benchmark increase, returns on holding LENZ Therapeutics are expected to decrease at a much lower rate. During a bear market, however, LENZ Therapeutics is likely to outperform the market. Additionally LENZ Therapeutics has an alpha of 0.8536, implying that it can generate a 0.85 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). LENZ Therapeutics Price Density |
| Price |
Predictive Modules for LENZ Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LENZ Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.LENZ Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. LENZ Therapeutics is not an exception. The market had few large corrections towards the LENZ Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold LENZ Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of LENZ Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.85 | |
β | Beta against Dow Jones | -0.07 | |
σ | Overall volatility | 4.80 | |
Ir | Information ratio | 0.16 |
LENZ Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of LENZ Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for LENZ Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| LENZ Therapeutics appears to be risky and price may revert if volatility continues | |
| LENZ Therapeutics was previously known as Graphite Bio and was traded on NASDAQ Exchange under the symbol GRPH. | |
| Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LENZ Therapeutics generates negative cash flow from operations | |
| LENZ Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 86.0% of the company shares are owned by institutional investors |
LENZ Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of LENZ Stock often depends not only on the future outlook of the current and potential LENZ Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. LENZ Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.1 M | |
| Cash And Short Term Investments | 185.9 M |
LENZ Therapeutics Technical Analysis
LENZ Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. LENZ Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of LENZ Therapeutics. In general, you should focus on analyzing LENZ Stock price patterns and their correlations with different microeconomic environments and drivers.
LENZ Therapeutics Predictive Forecast Models
LENZ Therapeutics' time-series forecasting models is one of many LENZ Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary LENZ Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about LENZ Therapeutics
Checking the ongoing alerts about LENZ Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for LENZ Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| LENZ Therapeutics appears to be risky and price may revert if volatility continues | |
| LENZ Therapeutics was previously known as Graphite Bio and was traded on NASDAQ Exchange under the symbol GRPH. | |
| Net Loss for the year was (124.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| LENZ Therapeutics generates negative cash flow from operations | |
| LENZ Therapeutics has a poor financial position based on the latest SEC disclosures | |
| Over 86.0% of the company shares are owned by institutional investors |
Additional Tools for LENZ Stock Analysis
When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.